Net Loss of Ortin Laboratories reported to Rs 4.14 crore in the quarter ended March 2024 as against net loss of Rs 0.20 crore during the previous quarter ended March 2023. Sales declined 90.41% to Rs 0.14 crore in the quarter ended March 2024 as against Rs 1.46 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 8.04 crore in the year ended March 2024 as against net loss of Rs 0.09 crore during the previous year ended March 2023. Sales declined 64.95% to Rs 2.11 crore in the year ended March 2024 as against Rs 6.02 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales0.141.46 -90 2.116.02 -65 OPM %-2178.57-2.05 --301.909.47 - PBDT-3.13-0.15 -1987 -6.850.17 PL PBT-3.18-0.18 -1667 -7.08-0.08 -8750 NP-4.14-0.20 -1970 -8.04-0.09 -8833 Powered by Capital Market - Live News

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Ortin Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 April 2024 .Powered by Capital Market - Live News

Net loss of Ortin Laboratories reported to Rs 2.79 crore in the quarter ended December 2023 as against net profit of Rs 0.46 crore during the previous quarter ended December 2022. Sales declined 87.93% to Rs 0.14 crore in the quarter ended December 2023 as against Rs 1.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.141.16 -88 OPM %-1864.2954.31 - PBDT-2.750.53 PL PBT-2.810.46 PL NP-2.790.46 PL Powered by Capital Market - Live News

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News